Eribulin Mesylate
- Product NDC
- 10019-080
- 11-digit product format
- 100190080
- Labeler code
- 10019
- Product ID
- 10019-080_d075592c-a613-41ff-975a-e0855110fb75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eribulin Mesylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Company
- Application
- ANDA217250
- Marketing category
- ANDA
- Marketing start
- 2024-10-01
- Substance
- ERIBULIN MESYLATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eribulin Mesylate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERIBULIN MESYLATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | AV9U0660CW |
| Rxcui | 1045456 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10019-080-01 | Eribulin Mesylate | 1 in 1 CARTON | INJECTION | 1 | | 4 |
| 10019-080-01 | Eribulin Mesylate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10019-080 | ERIBULIN MESYLATE INJECTION [BAXTER HEALTHCARE COMPANY] | 2 | Current NDC, 2 package rows | 20250514_62690292-b1de-46f1-b6e8-012a725f8c63.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 10019-080-01 | 10019008001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE | 2024-12-01 | No | No | Current |